Work

P3.18.41 A Phase II Study of Second-Line Cadonilimab, Bevacizumab and Docetaxel in Patients With Advanced NSCLC

Year: 2025

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2025.09.1056

Authors: J.C. Duan, B. Cao, W. Guo, B. Sun, L. Liu, J. Wang

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Peking University Third Hospital, Shanxi Provincial Cancer Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4415519402

FWCI:

Cites:

Cited by:

Related to: